Nektar Therapeutics (NKTR) Return on Equity [ROE] (2011 - 2026)
Nektar Therapeutics' Return on Equity [ROE] was -20.71% in Q2 2026, up 24.96 percentage points from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Return on Equity [ROE] at Nektar Therapeutics came in at -206.35%, down 82.25 percentage points from FY2024.
- Return on Equity [ROE] has now declined for seven consecutive years, with a five-year change of -170.55 percentage points (FY2020 to FY2025).
- In earlier years, Return on Equity [ROE] was -124.10% in FY2024 (-13.15 pp), -110.95% in FY2023 (-40.56 pp), -70.39% in FY2022 (-10.76 pp) and -59.64% in FY2021 (-23.83 pp).
- The Q2 2026 figure marks the highest quarterly Return on Equity [ROE] since Q1 2019.
- Compared with a year earlier, Return on Equity [ROE] was higher in two of the last six quarters, with an average year-over-year change of -17.38 percentage points.
- The best year-over-year quarter for Return on Equity [ROE] over five years was Q1 2026 (a gain of 299.63 percentage points); the worst was Q1 2025 (a drop of 208.82 percentage points).
- Per Business Quant data, NKTR's Return on Equity [ROE] in the three quarters before Q2 2026 was -45.67% (Q1 2026), -177.62% (Q4 2025) and -372.42% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Nektar Therapeutics | 1.44 Bn | -328.37 Mn | - | -20.71% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -20.71% |
| Mar 31, 2026 | -45.67% |
| Dec 31, 2025 | -177.62% |
| Sep 30, 2025 | -372.42% |
| Mar 31, 2025 | -345.30% |
| Dec 31, 2024 | -217.04% |
| Sep 30, 2024 | -261.80% |
| Jun 30, 2024 | -171.60% |
| Mar 31, 2024 | -136.47% |
| Dec 31, 2023 | -190.15% |
| Sep 30, 2023 | -164.83% |
| Jun 30, 2023 | -140.18% |
| Mar 31, 2023 | -136.57% |
| Dec 31, 2022 | -94.55% |
| Sep 30, 2022 | -104.29% |
| Jun 30, 2022 | -98.41% |
| Mar 31, 2022 | -76.32% |
| Dec 31, 2021 | -70.74% |
| Sep 30, 2021 | -58.06% |
| Jun 30, 2021 | -49.94% |
API Access
Nektar Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();